Suppression of host adaptive immune responses by Neisseria gonorrhoeae: Role of interleukin 10 and type 1 regulatory T cells

Mucosal Immunology

Volumn 7, Issue 1, 2014, Pages 165-176

  Liu, Y ^a   Liu, W ^a   Russell, M W ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY;

ADAPTIVE IMMUNITY; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL CLEARANCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GONORRHEA; IMMUNE DEFICIENCY; IMMUNOMODULATION; MOUSE; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SECONDARY INFECTION; TH1 CELL; TH17 CELL; TH2 CELL;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; GONORRHEA; IMMUNITY, INNATE; INTERLEUKIN-10; MICE; NEISSERIA GONORRHOEAE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS; VAGINA;

EID: 84888621162     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.36     Document Type: Article

References (40)

1. World Health Organization Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae. (WHO, Geneva, Switzerland, 2012).
2. Bolan, G.A., Sparling, P.F. & Wasserheit, J.N. The emerging threat of untreatable gonococcal infection. N. Engl. J. Med. 366, 485-487 (2012).
3. Hook, E.W. & Handsfield, H.H. Gonococcal infections in the adult. In Sexually Transmitted Diseases, 3rd edn, Holmes, K.K. & Sparling, P.F. & Ma° rdh, P.-A. & Lemon, S.M. & Stamm, W.E. & Piot, P. & Wasserheit, J.N., (eds) 451-466 (McGraw-Hill Health Professions Division, New York, NY, USA, 1999).
4. Cohen, M.S. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 351 (Suppl 3), 5-7 (1998).
5. Russell, M.W. &Hook, E.W. 3rd Gonorrhea. In Vaccines forBiodefense and Emerging and Neglected Diseases (Barrett, A.D.T. & Stanberry, L.R., eds) 963-981 (Academic Press, London, UK, 2009).
6. Zhu,W. et al. Vaccines for gonorrhea: can we rise to the challenge?. Front. Microbiol. 2, 124 (2011).
7. Plummer, F.A. et al. Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. J. Clin. Invest. 83, 1472-1476 (1989).
8. Ram, S. et al. Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J. Exp. Med. 193, 281-295 (2001).
9. Smith, H., Parsons, N.J. & Cole, J.A. Sialylation of neisserial lipopolysaccharide: a major influence on pathogenicity. Microb. Pathog. 19, 365-377 (1995).
10. Lewis, L.A., Burrowes, E., Rice, P.A. & Ram, S. Interactions of Neisseria with complement. In Neisseria: Molecular Mechanisms of Pathogenesis (Genco, C.A. & Wetzler, L., eds) 123-144 (Caister Academic Press, Norfolk, UK, 2010).
11. Boulton, I.C. & Gray-Owen, S.D. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat. Immunol. 3, 229-236 (2002).
12. Zhu, W. et al. Neisseria gonorrhoeae suppresses dendritic cell-induced, antigen-dependent CD4 T cell proliferation. PLoS One 7, e41260 (2012).
13. Feinen, B., Jerse, A.E., Gaffen, S.L. & Russell, M.W. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal Immunol. 3, 312-321 (2010).
14. Liu, Y. & Russell, M.W. Diversion of the immune response to Neisseria gonorrhoeae from Th17 to Th1/Th2 by treatment with anti-transforming growth factor beta antibody generates immunological memory and protective immunity. mBio 2, e00095-11 (2011).
15. Liu, Y. et al. Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-beta-dependent mechanisms. Mucosal Immunol. 5, 320-331 (2012).
16. Sabat, R. et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 21, 331-344 (2010).
17. Ouyang, W., Rutz, S., Crellin, N.K., Valdez, P.A. & Hymowitz, S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29, 71-109 (2011).
18. Roncarolo, M.G. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50 (2006).
19. Battaglia, M., Gregori, S., Bacchetta, R. & Roncarolo, M.G. Tr1 cells: from discovery to their clinical application. Semin. Immunol. 18, 120-127 (2006).
20. Kreisman, L.S. & Cobb, B.A. Glycoantigens induce human peripheral Tr1 cell differentiation with gut-homing specialization. J. Biol. Chem. 286, 8810-8818 (2011).
21. Gianfrani, C. et al. Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J. Immunol. 177, 4178-4186 (2006).
22. McGuirk, P., McCann, C. & Mills, K.H. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195, 221-231 (2002).
23. Kobayashi, R. et al. Induction of IL-10-producing CD4+ T-cells in chronic periodontitis. J. Dent. Res. 90, 653-658 (2010).
24. Cole, J.G., Fulcher, N.B. & Jerse, A.E. Opacity proteins increase Neisseria gonorrhoeae fitness in the female genital tract due to a factor under ovarian control. Infect. Immun. 78, 1629-1641 (2010).
25. Packiam, M. et al. Protective role of Toll-like receptor 4 in experimental gonococcal infection of female mice. Mucosal Immunol. 5, 19-29 (2012).
26. John, C.M., Liu, M. & Jarvis, G.A. Profiles of structural heterogeneity in native lipooligosaccharides of Neisseria and cytokine induction. J. Lipid Res. 50, 424-438 (2009).
27. Imarai, M. et al. Regulatory T cells are locally induced during intravaginal infection of mice with Neisseria gonorrhoeae. Infect. Immun. 76, 5456-5465 (2008).
28. Huber, S. et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3(-) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34, 554-565 (2011).
29. Feinen, B. & Russell, M.W. Contrasting roles of IL-22 and IL-17 in murine genital tract infection by Neisseria gonorrhoeae. Front. Immunol. 3, 11 (2012).
30. Song,W. et al. Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradioltreated mice. Vaccine 26, 5741-5751 (2008).
31. Liu, Y., Feinen, B. & Russell, M.W. New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the host. Front. Microbiol. 2, 52 (2011).
32. Criss, A.K. & Seifert, H.S. Neisseria gonorrhoeae suppresses the oxidative burst of human polymorphonuclear leukocytes. Cell. Microbiol. 10, 2257-2270 (2008).
33. Criss, A.K., Katz, B.Z. & Seifert, H.S. Resistance of Neisseria gonorrhoeae to non-oxidative killing by adherent human polymorphonuclear leucocytes. Cell. Microbiol. 11, 1074-1087 (2009).
34. Shafer, W.M., Qu, X., Waring, A.J. & Lehrer, R.I. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. USA 95, 1829-1833 (1998).
35. Packiam, M., Veit, S.J., Anderson, D.J., Ingalls, R.R. & Jerse, A.E. Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses. Infect. Immun. 78, 433-440 (2010).
36. Gagliardi, M.C. et al. Circulating levels of interleukin-17A and interleukin-23 are increased in patients with gonococcal infection. FEMS Immunol. Med. Microbiol. 61, 129-132 (2011).
37. Pantelic, M. et al. Neisseria gonorrhoeae kills carcinoembryonic antigen-related cellular adhesion molecule 1 (CD66a)-expressing human B cells and inhibits antibody production. Infect. Immun. 73, 4171-4179 (2005).
38. Sparling, P.F., Elkins, C.,Wyrick, P.B. & Cohen, M.S. Vaccines for bacterial sexually transmitted infections: a realistic goal?. Proc.Natl. Acad. Sci. USA 91, 2456-2463 (1994).
39. Jerse, A.E. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67, 5699-5708 (1999).
40. Chen, J.C., Chang, M.L. & Muench, M.O. A kinetic study of the murine mixed lymphocyte reaction by 5,6-carboxyfluorescein diacetate succinimidyl ester labeling. J. Immunol. Methods 279, 123-133 (2003).